Browsing Tag

Nasdaq:OPGN

OpGen Announces Publication of Results from the Acuitas AMR Gene Panel Multicenter Clinical Trial in…

James Pereira Feb 11, 2022

Publication demonstrates FDA cleared Acuitas AMR Gene Panel detects and differentiates a broad range of 28 AMR markers…
Read More...

OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for…

James Pereira Oct 4, 2021

Preliminary Total Revenue for Q3 2021 was approximately $1.2 millionCash as of September 30, 2021 was approximately…
Read More...